(Total Views: 240)
Posted On: 12/09/2019 12:28:30 PM
Post# of 1425
nice post from sello from another board:
sello Member Level Sunday, 12/08/19 08:11:33 AM
Re: None 0
Post # of 38272
I knew that PCT had something special here but after spending the last couple of days researching Candida Auris I realize just how vital this system is for an epidemic that is raising alarm around the globe.
This strain of fungus is like nothing ever seen before and though it has been purposely kept under the radar until recently to avoid panic, the CDC has put a priority focus on identification and isolation in the last couple of years.
The mortality rate for those affected is around 50%. In April of this year 539 cases were identified in the US. At the end of September there were 888 nationwide. At the current rate of growth it has been estimated that if no new anti-fungal and antibiotic drugs are created to treat this infection. and the others resistant infections, they will surpass cancer in death toll by the year 2050.
The reason PCT is targeting, and getting into the top New York hospitals is because New York is the epicenter of the US cases with 380 of the current cases acquired in New York hospitals. London has been hit hard as well which explains the recent installation there.
One of the aspects of Candida Auris and it's high resistance to both anti-fungal and standard disinfectants is the bio film that protects it. Right now the only approved environmental treatments approved by the CDC are chlorine based products.
So bleach does kill this as chlorine is it's base. The problem is that this thing is not contained to standard surface contamination so standard disinfecting protocol using bleach based products requiring human application is not sufficient. These spores are present in every part of a contaminated room, ceilings, fixtures, even electrical outlets. One hospital that had an outbreak of 72 cases in London had to close down the entire ICU and remove ceilings and walls before finally getting rid of the stuff.
This is where Hypoclorous acid, also having clorine as it's base and also approved as an effective treatment for C auris, comes into play. You can't use bleach through an electrostatic application because, unlike hypoclorous, it is toxic. This makes it nearly impossible to fully disinfect a room with bleach.
PCT has set themselves apart from the competition in the hypoclorous acid sector by offering a complete package of onsite production, electrostatic application, protocol software, and most important the patented tracking software as product life has always been one of the biggest concerns with the use of HOCL.
This is ground floor folks. I think the next step is a bridge to profitability with contract based lines of credit after that and explosive growth in the coming years.
PCTL!!
sello Member Level Sunday, 12/08/19 08:11:33 AM
Re: None 0
Post # of 38272
I knew that PCT had something special here but after spending the last couple of days researching Candida Auris I realize just how vital this system is for an epidemic that is raising alarm around the globe.
This strain of fungus is like nothing ever seen before and though it has been purposely kept under the radar until recently to avoid panic, the CDC has put a priority focus on identification and isolation in the last couple of years.
The mortality rate for those affected is around 50%. In April of this year 539 cases were identified in the US. At the end of September there were 888 nationwide. At the current rate of growth it has been estimated that if no new anti-fungal and antibiotic drugs are created to treat this infection. and the others resistant infections, they will surpass cancer in death toll by the year 2050.
The reason PCT is targeting, and getting into the top New York hospitals is because New York is the epicenter of the US cases with 380 of the current cases acquired in New York hospitals. London has been hit hard as well which explains the recent installation there.
One of the aspects of Candida Auris and it's high resistance to both anti-fungal and standard disinfectants is the bio film that protects it. Right now the only approved environmental treatments approved by the CDC are chlorine based products.
So bleach does kill this as chlorine is it's base. The problem is that this thing is not contained to standard surface contamination so standard disinfecting protocol using bleach based products requiring human application is not sufficient. These spores are present in every part of a contaminated room, ceilings, fixtures, even electrical outlets. One hospital that had an outbreak of 72 cases in London had to close down the entire ICU and remove ceilings and walls before finally getting rid of the stuff.
This is where Hypoclorous acid, also having clorine as it's base and also approved as an effective treatment for C auris, comes into play. You can't use bleach through an electrostatic application because, unlike hypoclorous, it is toxic. This makes it nearly impossible to fully disinfect a room with bleach.
PCT has set themselves apart from the competition in the hypoclorous acid sector by offering a complete package of onsite production, electrostatic application, protocol software, and most important the patented tracking software as product life has always been one of the biggest concerns with the use of HOCL.
This is ground floor folks. I think the next step is a bridge to profitability with contract based lines of credit after that and explosive growth in the coming years.
PCTL!!
(0)
(0)Scroll down for more posts ▼
